Add BrightSurf on Google Email

Treating bladder infections with viruses

Researchers at ETH Zurich have developed a rapid test that detects bladder infections using bacteriophages, which can identify the pathogenic bacteria in under four hours. The test also allows for tailored phage therapy, predicting patient response and increasing treatment effectiveness.

SourceETH Zurich·JournalNature Communications·TypeExperimental study·DateJul 21, 2023

Bacteria discreetly dwelling in throat revealed to be primary source of Strep A transmission

Research reveals that asymptomatic throat carriage of Streptococcus pyogenes is the primary source of Group A Streptococcus (GAS) infections in high-risk communities. This discovery challenges previous understanding of GAS transmission and has significant implications for public health approaches, vaccine development, and future research.

SourceThe Peter Doherty Institute for Infection and Immunity·JournalThe Lancet Microbe·TypeObservational study·DateJul 17, 2023

Pathogenic bacteria use a sugar in the intestinal mucus layer to infect the gut, study shows

A new study reveals that pathogenic bacteria fuel their growth by consuming sialic acid, a key component of the protective intestinal mucus layer. The findings suggest a potential treatment target for intestinal bacterial infections and chronic diseases linked to gut bacteria, including IBD and celiac disease.

SourceUniversity of British Columbia·JournalProceedings of the National Academy of Sciences·TypeObservational study·DateJul 3, 2023

Vaginal suppository containing lactobacilli can prevent recurrent cystitis in women

A study published in Frontiers in Microbiology found that administering vaginal suppositories with Lactobacillus crispatus can restore a healthy balance of vaginal microbiota and prevent recurrent cystitis. The researchers discovered that postmenopausal women with RC had significantly different bacterial communities compared to those w...

SourceOkayama University·JournalFrontiers in Microbiology·TypeObservational study·DateJul 3, 2023

HKUMed invents a novel microneedle array embedded with ultrasound-triggered antibacterial nanoparticles enabling a breakthrough treatment for skin infection

Researchers at HKUMed have developed a novel microneedle patch that uses ultrasound-responsive antibacterial nanoparticles to effectively treat skin infections caused by P. acnes bacteria. The treatment promotes pain-free delivery and facilitates skin repair, offering a non-antibiotic approach for acne and other skin conditions.

SourceThe University of Hong Kong·JournalScience Advances·TypeExperimental study·DateJun 28, 2023

Updated guidance shows how hospitals should protect patients from resistant infections

The updated guidance emphasizes the importance of antimicrobial stewardship to reduce MRSA infection rates. It also recommends surveillance for asymptomatic carriers and decolonization for those colonized with MRSA. Effective hand hygiene and cleaning practices remain crucial in preventing MRSA transmission.

SourceSociety for Healthcare Epidemiology of America·JournalInfection Control and Hospital Epidemiology·TypeLiterature review·DateJun 27, 2023

All the immunity, none of the symptoms

Researchers found that an iron-rich diet can prevent deadly symptoms in mice during active infection, while a functional adaptive immune system is required for immunity against future infections. The study paves the way for the development of new vaccines that could promote immunity for those with diarrheal diseases.

SourceSalk Institute·JournalScience Advances·TypeExperimental study·DateJun 23, 2023

“Choosing Wisely” interventions can reduce antibiotic overuse at safety-net hospitals, UCLA-led research suggests

A statewide pay-for-performance intervention based on Choosing Wisely reduced rates of inappropriate antibiotic prescriptions for acute respiratory tract infections from 43% to 25%. This reduction occurred without measurable harms at safety-net hospitals serving disadvantaged patients.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe American Journal of Managed Care·TypeExperimental study·DateJun 12, 2023

Study identifies a protein that could be a target for a vaccine against spotted fever

Researchers at the University of São Paulo identified a protein in Amblyomma ticks essential to their survival while feeding, making it a promising target for developing a vaccine. The study found that silencing gene expression of an inhibitor of apoptosis protein reduced bacterial proliferation and made ticks more resistant to infection.

SMART researchers discover novel combination therapy to counter antibiotic-resistant Mycobacterium abscessus infections

SMART researchers have discovered a novel combination therapy using rifaximin and clarithromycin to treat antibiotic-resistant Mycobacterium abscessus infections. The study found that rifaximin potentiates clarithromycin against M. abscessus, increasing its sensitivity and effectiveness in killing the bacteria.

SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalJAC-Antimicrobial Resistance·TypeExperimental study·DateJun 6, 2023

Previously unknown antibiotic resistance widespread among bacteria

A new study reveals that previously unknown antibiotic resistance genes are widespread in bacteria across various environments, including the human microbiome. The findings suggest that these genes can pose a significant threat to human health, highlighting the need for enhanced understanding of their development and spread.

SourceChalmers University of Technology·JournalMicrobiome·TypeData/statistical analysis·DateJun 5, 2023

New class of antibiotics to fight resistant bacteria

Researchers at the University of Zurich have developed a new class of antibiotics that target novel targets in bacterial metabolism, effectively fighting resistant bacteria. The peptides are highly effective, safe, and immune to resistance, offering hope for treating bacterial infections in patients.

SourceUniversity of Zurich·JournalScience Advances·TypeImaging analysis·DateJun 1, 2023

Anti-microbial nanonets display multi-functionality by mitigating inflammatory responses during sepsis

Pharmaceutical scientists from the National University of Singapore have developed multi-functional synthetic peptide nanonets for relieving inflammation caused by bacterial infection. These nanonets trap bacterial endotoxins and pro-inflammatory cytokines, achieving anti-inflammatory activity through selective binding.

SourceNational University of Singapore·JournalAdvanced Healthcare Materials·TypeExperimental study·DateMay 23, 2023

Researchers find compound that combats multidrug-resistant bacteria in less than one hour

Researchers have discovered a compound that can combat multidrug-resistant bacteria within one hour, including the ESKAPE group of pathogens. The compound, Pln149-PEP20, is a synthetic peptide inspired by molecules secreted by Lactobacillus plantarum and has been found to be highly active against MDR bacteria.

Study shows hospital policy allowing nurses to initiate C. difficile testing could reduce infection spread and associated morbidity

A new study suggests that allowing bedside nurses to independently order C. difficile testing can significantly reduce the time to receive test results, potentially decreasing clinical and economic burdens of CDI infections. The policy change also showed a decrease in patient infections and hospital economic costs.

SourceAssociation for Professionals in Infection Control·JournalAmerican Journal of Infection Control·TypeCase study·DateMay 11, 2023

Home measurement of blood oxygen levels by corona patients themselves easily applicable

A study by UMC Utrecht shows that corona patients can measure their blood oxygen levels at home using a pulse oximeter, feeling safe and experiencing more control. This method does not increase GP visits or hospitalization but contributes to relieving caregivers and keeping healthcare affordable.

SourceUniversity Medical Center Utrecht·JournalBritish Journal of General Practice·TypeRandomized controlled/clinical trial·DateMay 10, 2023

Antibiotic-resistant bacteria contaminates whole ICU - study

A study published in The Lancet Regional Health - Western Pacific found that carbapenem-resistant Acinetobacter baumannii (CRAB) contaminated the entire ICU, with samples detected on bed units, ventilators, and equipment. The researchers highlight the urgent need for targeted infection prevention and control measures to stem the global...

SourceUniversity of Birmingham·JournalThe Lancet Regional Health - Western Pacific·TypeObservational study·DateMay 9, 2023

NSU research into bacteria may lead to new ways of treating infections, improving human health

Researchers at Nova Southeastern University have made breakthroughs in understanding the complex relationship between beneficial and harmful bacteria. By studying how these bacteria communicate and work together, they hope to develop new treatments for infections, such as those caused by Staphylococcus aureus and Pseudomonas aeruginosa.

SourceNova Southeastern University·JournaleLife·DateMay 8, 2023